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Objective: To observe the effects of Lüfukang Capsules (ᕟ໡ᒋ㛊ಞ LFKC) on arrhythmia induced by ligation of 
coronary artery in dogs.  
Methods: Thirty dogs were randomly divided into 5 groups, the model group administrated with equal volume of  
distilled water, the positive control group administrated with Wenxin Granules (〇ᖗ乫㉦), and the small, medium 
and large dosage LFKC groups, 6 dogs in each group. Thirty minutes after medication, electrocardiogram was 
conducted and the time of arrhythmia occurrence, times of ventricular premature beat (VP), and incidence rates of 
ventricular tachycardia (VT) and ventricular fibrillation (VF) were recorded in the model dogs with arrhythmia 
induced by ligation of coronary artery.  
Results: Compared with the model group, the occurrence time of arrhythmia induced by the coronary artery 
ligation in the medium and large LFKC groups was significantly delayed (20.45±9.10 and 19.92±3.78, respectively, 
both P<0.05). The frequency of VP in the medium and large LFKC groups was also significantly decreased 
(8.17±6.62 and 3.83±2.79, respectively, both P<0.01). 
Conclusion: LFKC has anti-arrhythmic effects for the experimental arrhythmia induced by the ligation of coronary 
artery in dogs. 
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Arrhythmia refers to the abnormities in the frequency, 
rhythm and original site of cardiac impulse, which is one 
of the symptoms commonly seen in cardiovascular 
diseases. Arrhythmia not only occurs in the patients with 
cardiovascular diseases, but also in the patients of 
non-cardiovascular diseases or healthy persons. The 
clinical manifestations may include anxiety, palpitation, 
shortness of breath, weakness, chest pain, sweating, 
irritability, dizziness, unsound sleep, and pale or dark red 
tongue with petechiae and ecchymosis, and with yellow, 
greasy, thin white or less fur, and the pulse, knotted, 
intermittent, rapid, and uneven.1  
Arrhythmias may sometimes induce abnormal awareness 
of heart beat, making people feel only restlessness, and 
sometimes cause life-threatening emergencies, such as 
cardiac arrest or even sudden death. Rapid ventricular 
arrhythmia induced cardiac death is the most common 
cause of death in the United States, 250,000–500,000 
cases die each year, accounting for 10%–20% of the 
adult death rate.2 At present, there are many 
antiarrhythmics with different mechanisms. However, 
their clinical use is often limited by the frequent side 
effects, especially for the induced arrhythmic effects.3,4 
Lüfukang Capsules (ᕟ໡ᒋ㛊ಞ LFKC) has long been 
used for clinical treatment of arrhythmia with 
satisfactory therapeutic results, indicating that it is an 
effective antiarrhythmic.5-8 In the present study, the 
effects of LFKC for arrhythmia induced by ligation of 
the coronary artery were investigated in dogs. 
METHODS 
Medicines and Reagents1 
LFKC Capsules (Batch No.080805) were made by 
Teaching and Research Section of Medicament, 
Guangdong College of Pharmacy, which were diluted 
with distilled water just before use. Positive control 
medicine Wenxin Granules (〇ᖗ乫㉦ Batch No: 071007) 
were produced by Shandong Buchang Pharmaceutical 
Co. Ltd. Pentobarbital sodium (Batch No: 061206) was 
purchased from Beijing Chemical Reagent Co. Ltd.  
Animals 
Conventional thirty Beagle dogs (15 male and 15 female), 
weighing 8–12 kg, were supplied by Anhui Changlinhe 
Medical Science and Technology Co. Ltd, certificate of 
quality No: SCXK (ⱪ)2006-002. 
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Instruments 
Animal respirator was produced by Chengdu Taimeng 
Science and Technology Co. Ltd; XD-7100 electro- 
cardiograph was made by Shanghai Medical Electronic 
Instrument Factory. 
Animal Modeling and Grouping   
The experiment complied with the Animal Management 
Rule of the Ministry of Health, PRC, and the 
experimental protocol was approved by the Animal Care 
Committee of Guangdong College of Pharmacy. Thirty 
Beagle dogs were housed at the Animal Care Center of 
Guangdong College of Pharmacy.  
The arrhythmia model was prepared with a modified 
method according to previous description. 9 Five days 
after adaptive feeding, each animal was anesthetized with 
0.8% pentobarbital sodium via intraperitoneal injection, 
followed by endotracheal intubation, and mechanical 
ventilation. After thoracotomy, the heart was exposed 
and the left anterior descending branch of coronary artery 
was ligated with a complete and permanent occlusion, 
resulting in acute myocardial infarction. Additionally, an 
arterial catheter with heparin was inserted from the 
femoral artery to the abdominal aorta for continuous 
measurement of the arterial blood pressure. After the 
chest wall was sutured and artificial respiration was 
stopped, the dogs were transferred to specialized cages. 
The dogs were randomly divided (using random number 
table) into five groups: the model group, the positive 
control group, and the small, medium and large dose 
LFKC groups, 6 dogs (3 male and 3 female) in each 
group. 
Medicine Dosages and Administration Methods 
For the small dose LFKC group, 0.53 g crude drug/kg 
was intragastrically administrated, once per day. The 
dosage corresponded to 1 time of the clinical human dose 
according to the body surface area, or 1.6 times of 
clinical 60-kilogram adult dosage according to the body 
weight. Just before use, the contents of the LFKC 
Capsules were prepared into 1.91% solution with 
distilled water, which contained 10.60% crude drug, and 
5 mL/kg was given each time. 
For the medium dose LFKC group, 1.060 g crude 
drug/kg was intragastrically administrated, once per day. 
The dosage corresponded to 2 times of the clinical 
human dose according to the body surface area, or 3.2 
times of clinical 60-kilogram adult dosage according to 
the body weight. Just before use, the contents of the 
LFKC Capsules were prepared into 3.82% solution with 
distilled water, which contained 21.20% crude drug and 
5 mL/kg was given each time. 
For the large dose LFKC group, 2.120 g crude drug/kg 
was intragastrically administrated, once per day. The 
dosage corresponded to 4 times of clinical human dose 
according to the body surface area, or 6.4 times of 
clinical 60-kilogram adult dosage according to the body 
weight. Just before use, the contents of the LFKC 
Capsules were prepared into 7.64% solution with 
distilled water, which contained 42.40% crude drug and 
5 mL/kg was given each time. 
For the positive control group, 1.440 g crude drug/kg 
was intragastrically administrated, once per day. The 
dosage corresponded to 2 times of the clinical human 
dose according to the body surface area, or 3.2 times of 
clinical 60-kilogram adult dosage according to the body 
weight. Just before use, Wenxin Granules were prepared 
into 28.80% solution with distilled water, and 5 mL/kg 
was given each time.  
For the model group, 5 ml/kg distilled water was 
intragastrically administrated, once each day. 
Thirty min after intragastric administration, the left 
anterior descending branch of coronary artery was 
ligated. 
Indexes of Observation 
After the end of modeling, ECG was immediately 
conducted, and the time of arrhythmia occurrence, times 
of ventricular premature beats (VP) in one min, and 
incidence rates of ventricular tachycardia (VT) and 
ventricular fibrillation (VF) were recorded and 
calculated.  
Statistical Analysis  
The data were processed with software of SPSS, v12.0 
(SPSS Inc., Chicago, IL, USA) for windows, and 
expressed as x fs. Differences between two groups 
were assessed by unpaired Student’s t-test, and one-way 
ANOVA was used for comparison among multiple 
groups. P<0.05 was regarded as statistically significant 
difference. 
RESULTS 
As shown in the Table 1, LFKC significantly delayed the 
time of arrhythmia occurrence in coronary artery-ligated 
dogs, and reduced the times of VP and the incidence 
rates of VT and VF, with significant differences as 
compared with the model group (P <0.01 or 0.05). 
Table 1. Effects of LFKC on arrhythmia induced by ligation of coronary artery in dogs ( xfs, n=30) 
Groups Dosage (g/kg) Time of arrhythmia occurrence (min) Times 
of VP 
Rate of 
VT (%) 
Rate of 
VF (%) 
Model — 8.73±8.26 30.67±15.31 33.3 16.7 
Positive control 1.440 22.17±9.24*  9.67±12.23* 16.7 0 
Small LFKC dose 0.530 12.90±6.83 14.50±9.73 16.7 0 
Medium LFKC dose 1.060 20.45±9.10*  8.17±6.62** 16.7 16.7 
Large LFKC dose 2.120 19.92±3.78*  3.83±2.79** 0 0 
Notes: Compared with the model group, *P<0.05, **P<0.01.  
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SUMMARY 
According to the TCM theories, qi and blood are the 
fundamental substances for nourishing the heart. People 
with congenital deficiency, or infirm with age and 
prolonged diseases,are susceptible to arrhythmias 
because of the damage of qi and blood. LFKC is the 
authors’ experiential prescription for treating arrhythmia, 
which is composed of Hongshen (Radix Ginseng Rubra), 
Maidong (Radix Ophiopogonis), Shashen (Radix 
Adenophorae), Longyanrou (Dried Longan Pulp), 
Suanzaoren (Spine Date Seed), Danshen (Radix Salviae 
Miltiorrhizae), Wuweizi (Fructus Schisandrae) and 
Longchi (Fossilia Dentis Mastodi), etc. In the recipe, 
Hongshen (Radix Ginseng Rubra) and Longyanrou Dried 
Longan Pulp) functions to enrich the heart blood; 
Shashen (Radix Adenophorae) and Maidong (Radix 
Ophiopogonis) can reinforce the heart-yin; Suanzaoren 
(Spine Date Seed) has the effect of invigorating the 
heart-qi; Sheng Longchi (Fossilia Dentis Mastodi) may 
tranquilize the mind; Danshen (Radix Salviae 
Miltiorrhizae) can promote and regulate the flow of qi 
and blood. So, the whole recipe has functions of 
supplementing qi and nourishing yin, nourishing the 
blood to tranquilize the mind, resuming regular heart rate 
and relieving palpitation.  
The results from the present study show that LFKC can 
significantly delay the time of arrhythmia occurrence, 
reduce the frequency of VP and decrease the occurrence 
rates of VT and VF in the dog with coronary artery 
ligation, exerting better antiarrythmic effects as 
compared with Wenxin Granules, which can be used for 
preventing cardiac sudden death and other major cardiac 
events.10 
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